# Pexiganan Versus Placebo Control for the Treatment of Mild Infections of Diabetic Foot Ulcers

> **NCT01590758** · PHASE3 · COMPLETED · sponsor: **Dipexium Pharmaceuticals, Inc.** · enrollment: 189 (actual)

## Conditions studied

- Diabetic Foot Infection

## Interventions

- **DRUG:** Topical pexiganan cream 0.8%
- **DRUG:** Topical placebo cream
- **OTHER:** Standard wound care

## Key facts

- **NCT ID:** NCT01590758
- **Lead sponsor:** Dipexium Pharmaceuticals, Inc.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2014-06
- **Primary completion:** 2016-08
- **Final completion:** 2016-08
- **Target enrollment:** 189 (ACTUAL)
- **Last updated:** 2017-06-14


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01590758

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01590758, "Pexiganan Versus Placebo Control for the Treatment of Mild Infections of Diabetic Foot Ulcers". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT01590758. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*